Lightstone Ventures is a global venture capital fund dedicated to translating novel scientific breakthroughs into clinically and commercially meaningful therapies. We invest in biotech and medtech companies pioneering the big ideas poised to transform patient outcomes. We were founded in 2012 to empower visionary entrepreneurs with the resources and operational guidance necessary bring innovative therapeutics and technologies to the people who need them most. Our investment team has led deals resulting in 19 acquisitions and 20 initial public offerings over the last two decades. We have offices in Boston, Mass., Menlo Park, Calif., and Dublin, Ireland. For more information, visit www.lightstonevc.com.
View Top Employees from Lightstone VenturesWebsite | http://www.lightstonevc.com |
Revenue | $5.5 million |
Employees | 22 (16 on RocketReach) |
Founded | 2012 |
Address | 2884 Sand Hill Road Suite 121, Menlo Park, California, US |
Phone | (650) 388-3676 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Venture Capital and Private Equity Principals, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Medical Device, Pharmaceutical |
Web Rank | 13 Million |
Keywords | Anna Turetsky, Respect Trial For Tif, Lightstone, Evelo Seres, Lightstone Ventures |
Competitors | BioMedPartners, Boehringer Ingelheim Venture Fund, CalciMedica, Revitope |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular Lightstone Ventures employee's phone or email?
The Lightstone Ventures annual revenue was $5.5 million in 2024.
Brendan Kelly is the Vice President of Lightstone Ventures.
16 people are employed at Lightstone Ventures.
Lightstone Ventures is based in Menlo Park, California.
The NAICS codes for Lightstone Ventures are [54171, 5417, 54, 541, 541714].
The SIC codes for Lightstone Ventures are [873, 87].